|
1
|
Ridge CA, McErlean AM and Ginsberg MS:
Epidemiology of lung cancer. Semin Intervent Radiol. 30:93–98.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
MacDonagh L, Gray SG, Finn SP, Cuffe S,
O'Byrne KJ and Barr MP: The emerging role of microRNAs in
resistance to lung cancer treatments. Cancer Trea Rev. 41:160–169.
2015. View Article : Google Scholar
|
|
3
|
Landi MT, Zhao Y, Rotunno M, Koshiol J,
Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola
FM, et al: MicroRNA expression differentiates histology and
predicts survival of lung cancer. Clin Cancer Res. 16:430–441.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leidinger P, Brefort T, Backes C, Krapp M,
Galata V, Beier M, Kohlhaas J, Huwer H, Meese E and Keller A:
High-throughput qRT-PCR validation of blood microRNAs in non-small
cell lung cancer. Oncotarget. 26:4611–4616. 2016.
|
|
5
|
Inamura K and Ishikawa Y: MicroRNA in lung
cancer: Novel biomarkers and potential tools for treatment. J Clin
Med. 5:E362016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anglicheau D, Muthukumar T and
Suthanthiran M: MicroRNAs: Small RNAs with big effects.
Transplantation. 90:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Del Vescovo V, Cantaloni C, Cucino A,
Girlando S, Silvestri M, Bragantini E, Fasanella S, Cuorvo LV,
Palma PD, Rossi G, et al: miR-205 Expression levels in nonsmall
cell lung cancerdo not always distinguish adenocarcinomas from
squamous cell carcinomas. Am J Surg Pathol. 35:268–275. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Geurts P, Irrthum A and Wehenkel L:
Supervised learning with decision tree-based methods in
computational and systems biology. Mol Biosyst. 5:1593–1605. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Safavian SR and Landgrebe DA: A survey of
decision tree classifier methodology. IEEE Trans Systems Man
Cybernetics. 3:660–674. 1991. View
Article : Google Scholar
|
|
13
|
ENCODE Project Consortium, Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosenfeld N, Aharonov R, Meiri E,
Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S,
Levy A, et al: MicroRNAs accurately identify cancer tissue origin.
Nat Biotechnol. 26:462–469. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rosenwald S, Gilad S, Benjamin S, Lebanony
D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E, et
al: Validation of a microRNA-based qRT-PCR test for accurate
identification of tumor tissue origin. Mod Pathol. 23:814–823.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeong Y, Xie Y, Xiao G, Behrens C, Girard
L, Wistuba II, Minna JD and Mangelsdorf DJ: Nuclear receptor
expression defines a set of prognostic biomarkers for lung cancer.
PLoS Med. 7:e10003782010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu Y and Han J: Cancer classification
using gene expression data. Information Systems. 28:243–268. 2003.
View Article : Google Scholar
|
|
18
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sherafatian M: Tree-based machine learning
algorithms identified minimal set of miRNA biomarkers for breast
cancer diagnosis and molecular subtyping. Gene. 667:111–118. 2018.
View Article : Google Scholar
|
|
20
|
Colaprico A, Silva TC, Olsen C, Garofano
L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM,
Castiglioni I, et al: TCGAbiolinks: An R/Bioconductor package for
integrative analysis of TCGA data. Nucleic Acids Res. 44:e712015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization of squamous cell lung
cancers. Nature. 489:519–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gentleman R, Carey V, Huber W and Hahne F:
Genefilter: Methods for filtering genes from microarray
experiments. R package version 1(0) R package version
1.42.0.2011.
|
|
24
|
Kuhn M: Building predictive models in R
using the Caret package. J Stat Software. 28:1–26. 2008. View Article : Google Scholar
|
|
25
|
Risso D: EDASeq: Exploratory data analysis
and normalization for RNA-Seq. 2013.
|
|
26
|
Risso D, Ngai J, Speed TP and Dudoit S:
Normalization of RNA-seq data using factor analysis of control
genes or samples. Nat Biotechnol. 32:896–902. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hao M, Wang Y and Bryant SH: An efficient
algorithm coupled with synthetic minority over-sampling technique
to classify imbalanced PubChem BioAssay data. Anal Chim Acta.
806:117–127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Torgo L: Data mining with R: Learning with
case studies. 2016, CRC press; Boca Raton, FL, USA:
|
|
30
|
Williams GJ: Rattle: A data mining GUI for
R. R J. 1:45–55. 2009. View Article : Google Scholar
|
|
31
|
Therneau TM, Atkinson B and Ripley MB: The
rpart package. 2010.
|
|
32
|
Robin X, Turck N, Hainard A, Tiberti N,
Lisacek F, Sanchez JC and Müller M: pROC: An open-source package
for R and S+ to analyze and compare ROC curves. BMC Bioinformatics.
12:772011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Zhang X, Liu L, Li H, Yu J, Wang C
and Ren X: Clinical implication of microrna for lung cancer. Cancer
Biother Radiopharm. 28:261–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng B, Zhang K, Wang R and Chen L:
Non-small-cell lung cancer and miRNAs: Novel biomarkers and
promising tools for treatment. Clin Sci (Lond). 128:619–634. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Y, Bai Y, Zhang F, Wang Y, Guo Y and
Guo L: miR-126 inhibits non-small cell lung cancer cells
proliferation by targeting EGFL7. Biochem Biophys Res Commun.
391:1483–1489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhong M, Ma X, Sun C and Chen L: MicroRNAs
reduce tumor growth and contribute to enhance cytotoxicity induced
by gefitinib in non-small cell lung cancer. Chem Biol Interact.
184:431–438. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Su Y, Guarnera MA, Fang H and Jiang F:
Small non-coding RNA biomarkers in sputum for lung cancer
diagnosis. Mol Cancer. 15:362016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Võsa U, Vooder T, Kolde R, Vilo J,
Metspalu A and Annilo T: Meta-analysis of microRNA expression in
lung cancer. Int J Cancer. 132:2884–2893. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Boeri M, Verri C, Conte D, Roz L, Modena
P, Facchinetti F, Calabrò E, Croce CM, Pastorino U and Sozzi G:
MicroRNA signatures in tissues and plasma predict development and
prognosis of computed tomography detected lung cancer. Proc Natl
Acad Sci USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lebanony D, Benjamin H, Gilad S, Ezagouri
M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, et
al: Diagnostic assay based on hsa-miR-205 expression distinguishes
squamous from nonsquamous non-small-cell lung carcinoma. J Clin
Oncol. 27:2030–2037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu Y, Govindan R, Wang L, Liu PY, Goodgame
B, Wen W, Sezhiyan A, Pfeifer J, Li YF, Hua X, et al: MicroRNA
profiling and prediction of recurrence/relapse-free survival in
stage I lung cancer. Carcinogenesis. 33:1046–1054. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K
and Yang GH: MicroRNA-21 (miR-21) represses tumor suppressor PTEN
and promotes growth and invasion in non-small cell lung cancer
(NSCLC). Clin Chim Acta. 411:846–852. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hamamoto J, Soejima K, Yoda S, Naoki K,
Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, et al:
Identification of microRNAs differentially expressed between lung
squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep.
8:456–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Duan B, Guo T, Sun H, Cai R, Rui Q and Xi
Z: miR-205 as a biological marker in non-small cell lung cancer.
Biomed Pharmacother. 91:823–830. 2017. View Article : Google Scholar : PubMed/NCBI
|
